We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: Direct Oral Anticoagulants
MedXY News
EnglishTag

Direct Oral Anticoagulants

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Optimizing Antithrombotic Therapy After PCI in Atrial Fibrillation Patients: Insights from a Network Meta-Analysis
CardiologyLiệu pháp chống huyết khốiDirect Oral Anticoagulants

Optimizing Antithrombotic Therapy After PCI in Atrial Fibrillation Patients: Insights from a Network Meta-Analysis

By MedXY|Sep 1, 2026

This article explores the latest evidence on antithrombotic therapy after PCI in patients with atrial fibrillation, highlighting the balance between bleeding risk and prevention of ischemic events.

Balancing Risks: Safety Profiles of Antiseizure Medications in Epilepsy Patients on Direct Oral Anticoagulants
Cardiologybleeding riskepilepsy

Balancing Risks: Safety Profiles of Antiseizure Medications in Epilepsy Patients on Direct Oral Anticoagulants

By MedXY|Aug 18, 2026

This study reveals distinct thromboembolic, bleeding, and mortality risks based on antiseizure medication selection in epilepsy patients receiving direct oral anticoagulants, highlighting the critical role of ASM choice on patient safety an

Balancing Stroke and Cardiac Risks: DOACs versus Warfarin in Atrial Fibrillation with Mitral Stenosis
Cardiologyanticoagulation safetymitral stenosis

Balancing Stroke and Cardiac Risks: DOACs versus Warfarin in Atrial Fibrillation with Mitral Stenosis

By MedXY|Aug 11, 2026

This study evaluates the real-world effectiveness and safety of direct oral anticoagulants versus warfarin in Asian patients with atrial fibrillation and mitral stenosis, revealing higher stroke yet lower myocardial infarction risk with DOA

Switching from Warfarin to Direct Oral Anticoagulants in Frail Elderly Asian Patients with Atrial Fibrillation: Insights from a Korean Nationwide Study
CardiologyanticoagulationAsian Population

Switching from Warfarin to Direct Oral Anticoagulants in Frail Elderly Asian Patients with Atrial Fibrillation: Insights from a Korean Nationwide Study

By MedXY|Jul 3, 2026

In frail elderly Asian AF patients stable on warfarin, transitioning to DOACs increased risks of bleeding, thromboembolic events, and mortality, emphasizing cautious individualized management.

Standard-Dose DOACs Outperform Warfarin More Strongly in Asian Than Non-Asian Patients With Atrial Fibrillation
CardiologyAsian patientsatrial fibrillation

Standard-Dose DOACs Outperform Warfarin More Strongly in Asian Than Non-Asian Patients With Atrial Fibrillation

By MedXY|Apr 30, 2026

In a patient-level meta-analysis of 10,212 Asian and 61,471 non-Asian AF patients, standard-dose DOACs outperformed warfarin more strongly in Asians, with less stroke, major bleeding, and net clinical harm. Standard-dose therapy was favored

Standardized DOAC Interruption Protocols Result in Low Residual Levels, but Apixaban and Renal Impairment Merit Closer Monitoring
Cardiologybệnh huyết họcDirect Oral Anticoagulants

Standardized DOAC Interruption Protocols Result in Low Residual Levels, but Apixaban and Renal Impairment Merit Closer Monitoring

By MedXY|Feb 5, 2026

The DALI cohort study reveals that while current DOAC interruption protocols are generally effective, 13.1% of apixaban users maintain levels ≥30 ng/mL before surgery. However, these residual levels did not correlate with increased surgical

Low-Dose Apixaban vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: Insights from the ADALA Trial
CardiologyDirect Oral AnticoagulantsDual Antiplatelet Therapy

Low-Dose Apixaban vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: Insights from the ADALA Trial

By MedXY|Oct 8, 2025

The ADALA randomized trial compared low-dose apixaban with dual antiplatelet therapy post-LAA occlusion, demonstrating superior safety and reduced device-related thrombosis risk with low-dose anticoagulation at 3 months.

Impact of Prior Reperfusion Strategies on Early versus Late Direct Oral Anticoagulation in Ischemic Stroke: Insights from the ELAN Trial Subanalysis
Clinical UpdatesDirect Oral Anticoagulantsischemic stroke

Impact of Prior Reperfusion Strategies on Early versus Late Direct Oral Anticoagulation in Ischemic Stroke: Insights from the ELAN Trial Subanalysis

By MedXY|Oct 3, 2025

A subanalysis of the ELAN trial shows that prior reperfusion therapy does not alter the safety or efficacy outcomes of early versus late initiation of direct oral anticoagulants in ischemic stroke patients with atrial fibrillation.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities